Annual FCF
-$5.80 M
+$1.30 M+18.34%
31 December 2023
Summary:
ZIVO Bioscience annual free cash flow is currently -$5.80 million, with the most recent change of +$1.30 million (+18.34%) on 31 December 2023. During the last 3 years, it has fallen by -$3.21 million (-124.07%).ZIVO Free Cash Flow Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly FCF
-$1.08 M
-$461.30 K-73.96%
30 September 2024
Summary:
ZIVO Bioscience quarterly free cash flow is currently -$1.08 million, with the most recent change of -$461.30 thousand (-73.96%) on 30 September 2024. Over the past year, it has increased by +$884.50 thousand (+44.91%).ZIVO Quarterly FCF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM FCF
-$4.12 M
+$884.50 K+17.66%
30 September 2024
Summary:
ZIVO Bioscience TTM free cash flow is currently -$4.12 million, with the most recent change of +$884.50 thousand (+17.66%) on 30 September 2024. Over the past year, it has increased by +$2.41 million (+36.86%).ZIVO TTM FCF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
ZIVO Free Cash Flow Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +18.3% | +44.9% | +36.9% |
| 3 y3 years | -124.1% | +39.8% | +28.9% |
| 5 y5 years | -15.8% | +18.2% | +1.4% |
ZIVO Free Cash Flow High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3 years | -124.1% | +18.3% | -74.0% | +62.1% | at high | +52.1% |
| 5 y | 5 years | -124.1% | +18.3% | -219.4% | +62.1% | -76.3% | +52.1% |
| alltime | all time | <-9999.0% | +18.3% | <-9999.0% | +62.1% | <-9999.0% | +52.1% |
ZIVO Bioscience Free Cash Flow History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2024 | - | -$1.08 M(+74.0%) | -$4.12 M(-17.7%) |
| June 2024 | - | -$623.70 K(-63.3%) | -$5.01 M(-6.7%) |
| Mar 2024 | - | -$1.70 M(+137.4%) | -$5.37 M(-7.4%) |
| Dec 2023 | -$5.80 M(-18.3%) | -$715.70 K(-63.7%) | -$5.80 M(-11.2%) |
| Sept 2023 | - | -$1.97 M(+99.8%) | -$6.53 M(+8.0%) |
| June 2023 | - | -$985.70 K(-53.7%) | -$6.05 M(-5.0%) |
| Mar 2023 | - | -$2.13 M(+47.1%) | -$6.37 M(-10.3%) |
| Dec 2022 | -$7.10 M(+4.4%) | -$1.45 M(-2.8%) | -$7.10 M(-6.0%) |
| Sept 2022 | - | -$1.49 M(+14.0%) | -$7.56 M(-4.0%) |
| June 2022 | - | -$1.31 M(-54.4%) | -$7.87 M(-8.6%) |
| Mar 2022 | - | -$2.86 M(+50.5%) | -$8.61 M(+26.6%) |
| Dec 2021 | -$6.80 M(+162.8%) | -$1.90 M(+5.6%) | -$6.80 M(+17.2%) |
| Sept 2021 | - | -$1.80 M(-12.1%) | -$5.80 M(+27.1%) |
| June 2021 | - | -$2.05 M(+94.7%) | -$4.57 M(+59.8%) |
| Mar 2021 | - | -$1.05 M(+16.7%) | -$2.86 M(+10.4%) |
| Dec 2020 | -$2.59 M(-30.2%) | -$901.50 K(+59.8%) | -$2.59 M(+10.7%) |
| Sept 2020 | - | -$564.10 K(+66.1%) | -$2.34 M(-24.6%) |
| June 2020 | - | -$339.70 K(-56.6%) | -$3.10 M(-20.8%) |
| Mar 2020 | - | -$783.10 K(+20.2%) | -$3.91 M(+5.6%) |
| Dec 2019 | -$3.71 M(-26.0%) | -$651.30 K(-50.9%) | -$3.71 M(-11.3%) |
| Sept 2019 | - | -$1.33 M(+15.0%) | -$4.18 M(+2.4%) |
| June 2019 | - | -$1.15 M(+100.2%) | -$4.08 M(-13.3%) |
| Mar 2019 | - | -$576.20 K(-48.8%) | -$4.71 M(-5.9%) |
| Dec 2018 | -$5.01 M(+18.0%) | -$1.12 M(-8.5%) | -$5.01 M(-4.5%) |
| Sept 2018 | - | -$1.23 M(-30.9%) | -$5.24 M(+0.0%) |
| June 2018 | - | -$1.78 M(+103.5%) | -$5.24 M(+14.3%) |
| Mar 2018 | - | -$874.00 K(-35.8%) | -$4.59 M(+8.1%) |
| Dec 2017 | -$4.24 M(+66.8%) | -$1.36 M(+11.0%) | -$4.24 M(+14.7%) |
| Sept 2017 | - | -$1.23 M(+9.3%) | -$3.70 M(+27.0%) |
| June 2017 | - | -$1.12 M(+112.1%) | -$2.91 M(+25.8%) |
| Mar 2017 | - | -$529.50 K(-35.4%) | -$2.31 M(-9.0%) |
| Dec 2016 | -$2.54 M(+10.7%) | -$819.80 K(+86.1%) | -$2.54 M(+15.1%) |
| Sept 2016 | - | -$440.50 K(-16.1%) | -$2.21 M(-5.0%) |
| June 2016 | - | -$525.00 K(-30.8%) | -$2.33 M(-12.3%) |
| Mar 2016 | - | -$758.20 K(+55.8%) | -$2.65 M(+15.5%) |
| Dec 2015 | -$2.30 M(-16.0%) | -$486.50 K(-12.5%) | -$2.30 M(+8.9%) |
| Sept 2015 | - | -$556.10 K(-34.8%) | -$2.11 M(-23.8%) |
| June 2015 | - | -$852.50 K(+112.2%) | -$2.77 M(+12.6%) |
| Mar 2015 | - | -$401.80 K(+34.9%) | -$2.46 M(-10.2%) |
| Dec 2014 | -$2.74 M(-17.5%) | -$297.90 K(-75.5%) | -$2.74 M(-15.4%) |
| Sept 2014 | - | -$1.22 M(+123.9%) | -$3.23 M(+3.2%) |
| June 2014 | - | -$542.60 K(-20.3%) | -$3.13 M(-9.0%) |
| Mar 2014 | - | -$680.50 K(-14.4%) | -$3.44 M(+3.7%) |
| Dec 2013 | -$3.32 M(+86.7%) | -$794.60 K(-28.7%) | -$3.32 M(+15.2%) |
| Sept 2013 | - | -$1.11 M(+30.9%) | -$2.88 M(+28.9%) |
| June 2013 | - | -$851.90 K(+53.1%) | -$2.23 M(+24.2%) |
| Mar 2013 | - | -$556.30 K(+56.0%) | -$1.80 M(+1.2%) |
| Dec 2012 | -$1.78 M | -$356.70 K(-23.9%) | -$1.78 M(-8.6%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2012 | - | -$468.60 K(+12.3%) | -$1.94 M(+12.4%) |
| June 2012 | - | -$417.30 K(-21.9%) | -$1.73 M(+14.7%) |
| Mar 2012 | - | -$534.20 K(+2.0%) | -$1.51 M(+16.1%) |
| Dec 2011 | -$1.30 M(-11.6%) | -$523.70 K(+105.9%) | -$1.30 M(+37.0%) |
| Sept 2011 | - | -$254.40 K(+29.7%) | -$948.30 K(-5.3%) |
| June 2011 | - | -$196.20 K(-39.5%) | -$1.00 M(+14.3%) |
| Mar 2011 | - | -$324.50 K(+87.4%) | -$876.40 K(-40.4%) |
| Dec 2010 | -$1.47 M(+26.2%) | -$173.20 K(-43.7%) | -$1.47 M(-9.9%) |
| Sept 2010 | - | -$307.70 K(+333.4%) | -$1.63 M(-15.2%) |
| June 2010 | - | -$71.00 K(-92.3%) | -$1.92 M(-2.6%) |
| Mar 2010 | - | -$917.40 K(+173.4%) | -$1.97 M(+69.6%) |
| Dec 2009 | -$1.16 M(+10.3%) | -$335.50 K(-44.1%) | -$1.16 M(+28.5%) |
| Sept 2009 | - | -$600.30 K(+394.1%) | -$906.10 K(+102.3%) |
| June 2009 | - | -$121.50 K(+13.3%) | -$448.00 K(-41.1%) |
| Mar 2009 | - | -$107.20 K(+39.0%) | -$760.80 K(-27.9%) |
| Dec 2008 | -$1.06 M(-25.2%) | -$77.10 K(-45.8%) | -$1.06 M(-11.3%) |
| Sept 2008 | - | -$142.20 K(-67.3%) | -$1.19 M(-16.0%) |
| June 2008 | - | -$434.30 K(+8.0%) | -$1.42 M(+6.6%) |
| Mar 2008 | - | -$402.00 K(+90.3%) | -$1.33 M(-5.8%) |
| Dec 2007 | -$1.41 M(-36.3%) | -$211.20 K(-42.8%) | -$1.41 M(-15.7%) |
| Sept 2007 | - | -$369.30 K(+6.7%) | -$1.67 M(-19.8%) |
| June 2007 | - | -$346.00 K(-28.5%) | -$2.09 M(-4.4%) |
| Mar 2007 | - | -$483.90 K(+2.2%) | -$2.18 M(-1.4%) |
| Dec 2006 | -$2.21 M(+32.8%) | -$473.50 K(-39.6%) | -$2.21 M(-0.8%) |
| Sept 2006 | - | -$783.40 K(+77.6%) | -$2.23 M(+24.3%) |
| June 2006 | - | -$441.10 K(-14.3%) | -$1.79 M(-0.2%) |
| Mar 2006 | - | -$514.90 K(+4.8%) | -$1.80 M(+7.9%) |
| Dec 2005 | -$1.67 M(+30.1%) | -$491.40 K(+41.7%) | -$1.67 M(+12.2%) |
| Sept 2005 | - | -$346.90 K(-22.0%) | -$1.49 M(-4.6%) |
| June 2005 | - | -$444.90 K(+16.1%) | -$1.56 M(+8.5%) |
| Mar 2005 | - | -$383.30 K(+23.6%) | -$1.43 M(+12.0%) |
| Dec 2004 | -$1.28 M(+7260.3%) | -$310.00 K(-25.9%) | -$1.28 M(+29.6%) |
| Sept 2004 | - | -$418.20 K(+29.7%) | -$988.10 K(+73.4%) |
| June 2004 | - | -$322.50 K(+40.2%) | -$569.90 K(+130.4%) |
| Mar 2004 | - | -$230.00 K(+1221.8%) | -$247.40 K(+1321.8%) |
| Dec 2003 | -$17.40 K(<-9900.0%) | -$17.40 K(<-9900.0%) | -$17.40 K(<-9900.0%) |
| Sept 2003 | - | $0.00(0.0%) | $0.00(0.0%) |
| June 2003 | - | $0.00(0.0%) | $0.00(0.0%) |
| Mar 2003 | - | $0.00(0.0%) | $0.00(0.0%) |
| Dec 2002 | $0.00(0.0%) | $0.00(0.0%) | $0.00(0.0%) |
| Sept 2002 | - | $0.00(0.0%) | $0.00(0.0%) |
| June 2002 | - | $0.00(0.0%) | $0.00(0.0%) |
| Mar 2002 | - | $0.00(0.0%) | $0.00(0.0%) |
| Dec 2001 | $0.00(0.0%) | $0.00(0.0%) | $0.00(0.0%) |
| Sept 2001 | - | $0.00(0.0%) | $0.00(0.0%) |
| June 2001 | - | $0.00(0.0%) | $0.00(0.0%) |
| Mar 2001 | - | $0.00 | $0.00 |
| Dec 2000 | $0.00 | - | - |
FAQ
- What is ZIVO Bioscience annual free cash flow?
- What is the all time high annual FCF for ZIVO Bioscience?
- What is ZIVO Bioscience annual FCF year-on-year change?
- What is ZIVO Bioscience quarterly free cash flow?
- What is the all time high quarterly FCF for ZIVO Bioscience?
- What is ZIVO Bioscience quarterly FCF year-on-year change?
- What is ZIVO Bioscience TTM free cash flow?
- What is the all time high TTM FCF for ZIVO Bioscience?
- What is ZIVO Bioscience TTM FCF year-on-year change?
What is ZIVO Bioscience annual free cash flow?
The current annual FCF of ZIVO is -$5.80 M
What is the all time high annual FCF for ZIVO Bioscience?
ZIVO Bioscience all-time high annual free cash flow is $0.00
What is ZIVO Bioscience annual FCF year-on-year change?
Over the past year, ZIVO annual free cash flow has changed by +$1.30 M (+18.34%)
What is ZIVO Bioscience quarterly free cash flow?
The current quarterly FCF of ZIVO is -$1.08 M
What is the all time high quarterly FCF for ZIVO Bioscience?
ZIVO Bioscience all-time high quarterly free cash flow is $0.00
What is ZIVO Bioscience quarterly FCF year-on-year change?
Over the past year, ZIVO quarterly free cash flow has changed by +$884.50 K (+44.91%)
What is ZIVO Bioscience TTM free cash flow?
The current TTM FCF of ZIVO is -$4.12 M
What is the all time high TTM FCF for ZIVO Bioscience?
ZIVO Bioscience all-time high TTM free cash flow is $0.00
What is ZIVO Bioscience TTM FCF year-on-year change?
Over the past year, ZIVO TTM free cash flow has changed by +$2.41 M (+36.86%)